Evidence supporting the use of: Vitamin D3
For the health condition: Osteoporosis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Vitamin D3 (cholecalciferol) is scientifically validated as an important component in the prevention and management of osteoporosis. Osteoporosis is characterized by decreased bone mass and increased fracture risk, often resulting from impaired bone remodeling. Vitamin D3 plays a central role in calcium and phosphorus homeostasis by promoting their absorption in the intestines, which is necessary for proper bone mineralization. Deficiency in vitamin D can lead to decreased calcium absorption, secondary hyperparathyroidism, bone loss, and increased fracture risk.

Multiple randomized controlled trials and meta-analyses have shown that vitamin D supplementation, particularly when combined with calcium, can reduce bone loss and lower the risk of fractures, especially in older adults and postmenopausal women. For example, a 2014 meta-analysis in Lancet Diabetes & Endocrinology found that combined vitamin D and calcium supplementation reduced fracture risk, though the effect of vitamin D alone is less pronounced if calcium intake is adequate. Guidelines from organizations such as the National Osteoporosis Foundation and the Endocrine Society recommend vitamin D supplementation for individuals at risk of osteoporosis or with documented deficiency.

However, while robust evidence supports vitamin D3's role in bone health and osteoporosis prevention, optimal dosing and the benefit of supplementation in vitamin D-sufficient individuals remain areas of active research. Overall, there is strong scientific support for using vitamin D3 to support bone health and help manage osteoporosis, particularly as part of a broader strategy including calcium intake and lifestyle measures.

More about vitamin D3
More about Osteoporosis